Incamake ku bwoko bw'uturemangingo twa B-ALL ku bantu bakuru
Ku ya 15 Mutarama 2025, Shanghai – Isuzuma riherutse gusohoka mu kinyamakuru Amaraso itanga isesengura ryimbitse ry’ubwoko bw’uturemangingo twa B-cell Acute Lymphoblastic Leukemia (B-ALL) ku bantu bakuru, kanseri idakunze kugaragara kandi ikomeye ifite ingaruka mbi cyane ku bantu bakuru ugereranyije n’abana. Mu myaka makumyabiri ishize, ubushakashatsi ku byerekeye genomike bwagaragaje ubwoko burenga 20 butandukanye bwa B-ALL, buri bumwe bufite ingaruka zihariye ku buryo bwo kuvura no ku buvuzi.
Nubwo uburyo bwo kuvura bukoresheje imiterere y’uturemangingo bwahinduye ingamba zo kuvura abana B-ALL, imiterere y’uturemangingo twa B-ALL y’abantu bakuru ntabwo irasobanuka neza. Iri suzuma rigaragaza ibitekerezo by’ingenzi ku bwoko butandukanye bw’uturemangingo tw’uturemangingo mu barwayi bakuru kandi rishimangira ko ari ngombwa gushyira mu bikorwa isuzumabumenyi rya genetiki mu gusuzuma buri gihe kugira ngo habeho ingamba zo kuvura zihariye.
Ibyavumbuwe by'ingenzi:
-
Philadelphia Chromosome-Positive (Ph+) B-ALL:
Ikigaragara cyane mu bantu bakuru, cyane cyane ku bantu barengeje imyaka 55, Ph+ B-ALL ituruka kuri gene ya BCR::ABL1 fusion. Kuva kera bifitanye isano no kuba hari ingaruka mbi, guhuza imiti igabanya ubukana bwa tyrosine kinase (TKIs) n'uturemangingo tw’umubiri twibasiwe, nka blinatumomab, byazamuye cyane umubare w’abazima. Ibimenyetso bigaragara bigaragaza itandukaniro rikomeye ry’ibinyabuzima muri Ph+ B-ALL, bishimangira akamaro k’ibimenyetso bya molekile nka IKZF1 mu gushyira mu byiciro ibyago no gutegura uburyo bwo kuvura. -
Impinduka nke mu mikorere y'amaraso mu mubiri n'impinduka za TP53:
Kugabanuka kw'amaraso mu maraso, bigaragazwa n'umubare wa chromosomes uri hagati ya 30 na 39, bikunze kugaragara mu bantu bakuru kandi bifitanye isano n'umusaruro mubi. Ubushakashatsi buherutse kugaragaza uruhare rwa TP53 mutations, akenshi ifitanye isano na clonal hematopoiesis, mu gutera iyi groupe y'indwara zikomeye. Ibyavuye mu bushakashatsi bigaragaza ko izi mpinduka zitagize ingaruka gusa ku ntangiriro y'indwara ahubwo zishobora no gufasha ingamba zo kugabanya ubukana bw'indwara. -
Ivugurura rya KMT2A:
Kugaragara kenshi mu bantu bakuru bakuze, gukosora KMT2A bifitanye isano n'umusaruro mubi. Uburyo bushya bwo kuvura, nko gukumira menin, bufite icyizere cyo gukemura ikibazo cyo kudakira kw'iyi ndwara. -
Ubwoko buke bw'indwara n'uburyo bwo kuvura bukiri bushya:
Ubwoko bw'utundi duce nka TCF3::PBX1 na TCF3::HLF fusions, nubwo bidakunze kugaragara, bigaragaza itandukaniro rikomeye ry'ibinyabuzima n'ubuvuzi. Amakuru ajyanye n'ibizamini mbere yo kuvurwa agaragaza ko umuntu ashobora kwita ku bintu bishya nka venetoclax na BET inhibitors, bityo bikaba ari byo bitanga uburyo bushya bwo kuvura.
Ingaruka z'ubuvuzi:
Isuzuma risaba ko hashyirwaho uburyo bugezweho bwo gusesengura genome, harimo no gusesengura inyandiko zose, kugira ngo hamenyekane ubwoko bwihariye bw'uturemangingo twa B-ALL y'abantu bakuru. Ubu buryo bushobora kongera ibyiciro by'ibyago, bugafata ibyemezo byo kuvura, kandi bugateza imbere gukurikirana indwara nke zisigaye (MRD).